Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03395847
Title A Study of Pembrolizumab Monotherapy or in Combination With Other Agents in Patients With Previously Treated Advanced Gastroesophageal Adenocarcinoma
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center

gastroesophageal junction adenocarcinoma


Pembrolizumab + Ramucirumab


Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.